U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784569) titled 'APEX-STROKE Adaptive Platform Trial for Stroke' on July 20.
Brief Summary: Stroke remains one of the leading causes of death and disability, worldwide. Despite advances in stroke management, only a limited number of acute treatments-including thrombolysis, endovascular thrombectomy, hemicraniectomy, stroke unit care, and aspirin-have demonstrated clear benefit, highlighting the need for widely applicable interventions that improve outcomes. Although randomized controlled trials remain the most reliable method for evaluating treatment efficacy, conventional designs typically assess a single intervention under fixed assumptions and ar...